Peripheral and Hepatic Vein Cytokine Levels in Correlation with Non-Alcoholic Fatty Liver Disease (NAFLD)-Related Metabolic, Histological, and Haemodynamic Features-Reference-Cited by-同舟云学术

Peripheral and Hepatic Vein Cytokine Levels in Correlation with Non-Alcoholic Fatty Liver Disease (NAFLD)-Related Metabolic, Histological, and Haemodynamic Features

Published:2015-11-24 Issue:11 Volume:10 Page:e0143380
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Vonghia Luisa,Magrone Thea,Verrijken An,Michielsen Peter,Van Gaal Luc,Jirillo Emilio,Francque Sven

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference53 articles.

1. The burden of liver disease in Europe: a review of available epidemiological data;M Blachier;Journal of hepatology,2013

2. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis;P Angulo;Hepatology,1999

3. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association;N Chalasani;Hepatology,2012

4. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis;QM Anstee;Nature reviews Gastroenterology & hepatology,2013

5. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis;H Tilg;Hepatology,2010

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of the type 3 cytokines IL-17 and IL-22 in modulating metabolic dysfunction-associated steatotic liver disease;Frontiers in Immunology;2024-08-02

2. Immune system dysregulation in the pathogenesis of non-alcoholic steatohepatitis: unveiling the critical role of T and B lymphocytes;Frontiers in Immunology;2024-08-01

3. Gut Microbiota and Sinusoidal Vasoregulation in MASLD: A Portal Perspective;Metabolites;2024-06-07

4. Spleen volume is independently associated with non-alcoholic fatty liver disease, liver volume and liver fibrosis;Heliyon;2024-04

5. Immune cell balance as potential biomarker of progressing non-alcoholic fatty liver disease;Genes & Cells;2024-03-28